Relay Therapeutics, Inc. (RLAY) vs Tarsus Pharmaceuticals, Inc. (TARS)
- Relay Therapeutics, Inc. RLAY 16.28 −5.90%
- Tarsus Pharmaceuticals, Inc. TARS 68.07 −4.11%
Relay Therapeutics, Inc. and Tarsus Pharmaceuticals, Inc. are both Biotechnology companies. Relay Therapeutics, Inc. and Tarsus Pharmaceuticals, Inc. are of similar size ($3.8B and $3.5B). Tarsus Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 105.2% against −74.3%. Tarsus Pharmaceuticals, Inc. has the higher net margin (−7.67% vs −2,594.2%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Tarsus Pharmaceuticals, Inc. leads on 11 and Relay Therapeutics, Inc. on 5.
Valuation
Profitability
| Metric | RLAY | TARS | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 93.28% | 65.16% |
| Operating margin | (2,815.49%) | (8.00%) | 0.00% |
| Net margin | (2,594.20%) | (7.67%) | 0.00% |
| Free cash flow margin | (1,924.59%) | 9.24% | 0.00% |
| Return on equity | (36.77%) | (13.68%) | (56.36%) |
| Return on assets | (33.72%) | (8.40%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack